← back to search

Linlin Zhao

Shenyang University of Technology · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Ubiquitin and proteasome pathways, Cancer-related molecular mechanisms research, Immune Cell Function and Interaction, and biodegradable polymer synthesis and properties.
h-index
28
citations
2,893
works
101
NIH funding
primary concept
Medicine
email

Recent publications

Targeting <scp>SHP</scp>‐1‐Mediated Inhibition of <scp>STAT3</scp> and <scp>ERK</scp> Signalling Pathways Rescues the Hyporesponsiveness of <scp>MHC</scp>‐I‐Deficient <scp>NK</scp>‐<scp>92MI</scp>
Cell Proliferation 2025cited by 3position: middledoi
Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia
Molecular Biology Reports 2023cited by 1position: middledoi
Histone demethylase KDM3C regulates the lncRNA GAS5–miR‐495‐3p–PHF8 axis in cardiac hypertrophy
Annals of the New York Academy of Sciences 2022cited by 10position: firstdoi
Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL
Investigational New Drugs 2021cited by 40position: firstdoi
A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia
Journal of Translational Medicine 2021cited by 21position: middledoi
MiR-17-5p-mediated endoplasmic reticulum stress promotes acute myocardial ischemia injury through targeting Tsg101
Cell Stress and Chaperones 2020cited by 33position: firstdoi
Growth inhibition and suppression of the mTOR and Wnt/β‐catenin pathways in T‐acute lymphoblastic leukemia by rapamycin and <i>MYCN</i> depletion
Hematological Oncology 2020cited by 8position: middledoi
Preventive Effect of Albumin Nano TPA Gene Plasmid Ultrasound Microbubble Carrier System on Thrombosis after Cardiac Valve Replacement
Journal of Chemistry 2020cited by 1position: middledoi
<i><scp>MYCN</scp></i> is a novel oncogenic target in adult B‐<scp>ALL</scp> that activates the Wnt/β‐catenin pathway by suppressing <i><scp>DKK</scp>3</i>
Journal of Cellular and Molecular Medicine 2018cited by 28position: middledoi
Establishment and characterization of a GES‑1 human gastric epithelial cell line stably expressing miR‑23a
Oncology Letters 2018cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yinghua Li · Qingdao Agricultural University5 papers (2018–2023)Lili Sun · Ministry of Education of the People's Republic of China5 papers (2018–2023)Zhibo Guo · Harbin Medical University5 papers (2018–2023)Leilei Lin · Harbin Medical University4 papers (2018–2023)Desheng Kong · Beijing Enterprises (China)4 papers (2020–2023)Sicheng Bian · Case Western Reserve University3 papers (2021–2023)Qi Feng · Hebei Medical University2 papers (2020–2022)Naishi Wu · Harbin Medical University2 papers (2020–2020)YuHuang Wang · University of Maryland, College Park2 papers (2021–2021)Yanqiu Zhao · Harbin Medical University2 papers (2018–2020)Shengjin Fan · Harbin Medical University2 papers (2018–2020)Z. An · Harbin Medical University1 papers (2025–2025)Xin Zhang · Macau University of Science and Technology1 papers (2025–2025)Xin Wang · Chinese University of Hong Kong1 papers (2025–2025)Xi Chen · Harbin Medical University1 papers (2020–2020)Lu Xu · Roswell Park Comprehensive Cancer Center1 papers (2025–2025)Qi Li · Tsinghua University1 papers (2023–2023)Qi Li · Chinese PLA General Hospital1 papers (2021–2021)Qi Li · Harbin Medical University1 papers (2021–2021)Li Chen · Anhui Medical University1 papers (2018–2018)